![]() |
|
![]() |
|
|
COMPOSITION
|
|
Bronchial Asthma is characterized by Hyper-responsiveness of tracheo-bronchial smooth muscle to variety of stimulation. This results in narrowing of air tubes accompanied by secretion & mucosal edema. Asthma is now recognized to be an inflammatory condition i.e.inflammation underlying hyper reactivity. |
||
|
Trigger
Factors |
||
|
|
||
|
SALSOL stimulates b2 receptors present at bronchial smooth muscle cells.This leads to activations of certain enzymes such as adenyl cyclase and protein This is release to smooth muscle relaxation and symptomatic relief from bronchial asthma |
||
|
Following inhalation
the onset of action is 5-15 minutes and action lasts for 3-6 hours.SALSOL
is absorbed gradually from bronchi after inhalation and a fraction of
this dose is absorbed from G.I.T.
INDICATIONS
|
||
|
DOSAGE |
||
|
Patients sensitive to sympathomimetics & sensitive to sulfites. Can cause teratogenesis in the developing fetus. Product Highlights
|
||
| Learn More . . . |
| Composition |
| Indications |
| Dosage |
| Contraindications |
| | Home | Products | Marketing | Distribution | Link | Contacts | Sitemap | | ||
| DISCLAIMER |© KEE Pharma Ltd. 2004 | Powered By : A.G. WEBSOLUTIONS | |